XNW5004 combined with CHOEP (incremental) Clinical Trials

1 actively recruiting trial

Also known as: XNW5004, cyclophosphamide, doxorubicin, etoposide, prednisone acetate tablet +1 more

Pipeline

Phase 1/2: 1

Top Sponsors

Evopoint Biosciences Inc.1

Indications

Peripheral T Cell Lymphoma1
Non-hodgkin Lymphoma1
Cancer1

Other1 trial

Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell Lymphoma

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.